Looking to publish in Drug Healthcare and Patient Safety? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginDrug, Healthcare and Patient Safety is an international, peer-reviewed, open-access journal exploring patient safety issues across the healthcare continuum from diagnosis and screening through treatment, drug therapy, and surgery. It publishes reviews, original research, clinical, epidemiological, and post-marketing surveillance studies, risk management, health literacy, educational programs, safety guidelines, adverse reaction case reports, drug utilization studies, intervention research, and policy research focused on healthcare safety. Study protocols, animal and in vitro toxicity studies are out of scope, and the journal will no longer consider meta-analyses for publication.
Looking to publish in Drug Healthcare and Patient Safety? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Drug Healthcare and Patient Safety accepts the following article types. Click on an article type to view submission instructions.
Original Research Papers
Reviews
Meta-Analyses
Case Reports
Invited Reviews
Recent Publications
Seasonal Variation in Reporting of Venous Thromboembolism in a Spontaneous Adverse Event Reporting System: Analysis of the Japanese Adverse Drug Event Report Database
Hiroyuki Tanaka, Toshihiro Ishii
Quality and Timeliness of Pharmacovigilance Reporting in Malawi: A Cross-Sectional Analysis of Individual Case Safety Reports
Francis Kachidza Chiumia, Frider T Chimimba, Evans Chimayi Chirambo, Ian Peter Manja, Theophilus Rolland Chadza, Wilfred Kantchilala, Peter Mchenga, Happy Magwaza Nyirongo, Wyson Mbewe Mkanda, Felix Khuluza
Chemotherapy-Induced Toxicities in Pediatric Cancer Patients in Tanzania [Letter]
Stanley Mwita
Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report
Tsung-Kun Lin, Chih-Feng Chang, Gwo-Ping Jong
Computed Tomography Diagnostic Reference Levels Worldwide and in Jordan: Implications for Patient Dose Reduction
Ammar Oglat, Suhaib Shdaifat, Mohannad Sayah, Ahmed Abukonna, Wadah Khogali
Frequently asked questions
How long does it take to publish?
49 days average from submission to first editorial decision; 4 days average from editorial acceptance to publication
Reformat to Drug Healthcare and Patient Safety using Livewrite PremiumIs a cover letter required?
A point-by-point covering letter is required when submitting a revised manuscript after peer review.
Reformat to Drug Healthcare and Patient Safety using Livewrite PremiumWhat are the publication costs?
Open access costs may be covered by a Taylor & Francis open access agreement; no journal-specific APC is stated.
Reformat to Drug Healthcare and Patient Safety using Livewrite Premium